Technical aspects of enteral nutrition.

Keymling, Michael

doi:10.1136/gut.35.1_suppl.s77

Cited by 22 publications

(13 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In a prospective study comparing nutrition by percutaneous endoscopic gastrostomy (PEG) and by a nasogastric tube (NG), Lees et al [8] demonstrated that both techniques were equivalent with regard to weight maintenance in cancer patients treated by radiotherapy, but PEG tubes were associated with greater advantages in term of mobility, cosmesis, and quality of life than NG.…”

Section: Discussionmentioning

confidence: 97%

Comparison between nasogastric tube feeding and percutaneous fluoroscopic gastrostomy in advanced head and neck cancer patients

Magné

Marcy

Foa

et al. 2001

European Archives of Oto-Rhino-Laryngology

View full text Add to dashboard Cite

Wasting is a major complication of advanced head and neck cancer and the aim of this study was to compare nasogastric tube feeding (NG) and percutaneous fluoroscopic gastrostomy (PFG) in these patients. The goal of these two methods of nutritional support was to improve or maintain the initial nutritional status during treatment. A total of 90 patients, all stage IV oropharynx or hypopharynx tumor, were reviewed from a prospective databank. All these patients were treated by concomitant chemotherapy and twice-daily continuous radiotherapy with no acceleration. Fifty patients were managed by PFG, and the rest by NG. Mechanical failure, duration of feeding, complications, nutritional evaluation and quality of life were analysed. Mechanical failure occurred in 32 of the 40 NG patients and in seven of the gastrostomy group. In the PFG group, 80% of patients conserved their nutritional support after the end of the radiotherapy, none patient in the NG group. In the PFG group, two presented a wound infection and six had aspiration pneumonia while in the NG group, 21 had aspiration pneumonia probably due to the NG tube (gastroesophageal reflux). The feeding methods were found to be equally effective at maintaining body weight and body mass index at time 1 (3 weeks) and at time 2 (6 weeks). Advantages were associated with PFG cosmesis, mobility and quality of life. PFG is a safe and effective method of providing enteral nutrition during treatment to patients with advanced head and neck cancer and offers important advantages over NG.

show abstract

Section: Discussionmentioning

confidence: 97%

Comparison between nasogastric tube feeding and percutaneous fluoroscopic gastrostomy in advanced head and neck cancer patients

Magné

Marcy

Foa

et al. 2001

European Archives of Oto-Rhino-Laryngology

View full text Add to dashboard Cite

show abstract

“…The enteral route maintains the GI mucosal integrity and immunity, important in this population of patients who are at high risk for gastric ulcers, bacterial overgrowth, and sepsis [2,5,18,32,33,35]. Institution of bolus feeding allows patients to maintain normal feeding routine, facilitating early ambulation which reduces the risk of postoperative pulmonary and thromboembolic complications in this high-risk population.…”

mentioning

confidence: 99%

“…Institution of bolus feeding allows patients to maintain normal feeding routine, facilitating early ambulation which reduces the risk of postoperative pulmonary and thromboembolic complications in this high-risk population. Finally, enteral feeding avoids many of the complications related to intravenous parenteral nutrition (TPN), including venous thrombosis, hyperglycemia, and line sepsis, as well as the exorbitant costs associated with TPN [18,33].…”

mentioning

confidence: 99%

The introducer technique is the optimal method for placing percutaneous endoscopic gastrostomy tubes in head and neck cancer patients

et al. 2006

View full text Add to dashboard Cite

show abstract

“…From a practical standpoint, several methods are available for tube feeding [7,11]: nasogastric tube, PEG, PFG and surgical endoscopic gastrostomy [2]. PEG feeding has a number of advantages, including greater mobility, comesis, and improved quality of life [14].…”

Section: Discussionmentioning

confidence: 99%

Systematic percutaneous fluoroscopic gastrostomy for concomitant radiochemotherapy of advanced head and neck cancer: optimization of therapy

Marcy

Magné

Bensadoun

et al. 2000

Supportive Care in Cancer

View full text Add to dashboard Cite

Wasting is a major complication of advanced head and neck cancer. Concomitant chemotherapy and twice-daily continuous radiotherapy with no acceleration represents a promising treatment modality for these tumors, but increases the risk of mucositis. This report describes the results achieved with percutaneous fluoroscopic gastrostomy (PFG) and its impact on the quality of life of patients with head and neck cancer in terms of their nutritional status. A total of 50 stage IV tumors of the oropharynx and hypopharynx recorded in a prospective database were reviewed retrospectively. All patients were managed by PFG, which was found to be a safe and effective technique with no technical failures. PFG feeding resulted in a mean increase in body weight of 2.5 kg within 3 weeks. The body mass index (BMI) was maintained at 3 and 6 weeks. Minor complications occurred, but no major complications were noted. The overall procedure-related mortality rate was nil. Further prospective investigations are necessary to determine whether treatment of wasting improves patient survival.

show abstract

Technical aspects of enteral nutrition.

Cited by 22 publications

References 20 publications

Comparison between nasogastric tube feeding and percutaneous fluoroscopic gastrostomy in advanced head and neck cancer patients

Comparison between nasogastric tube feeding and percutaneous fluoroscopic gastrostomy in advanced head and neck cancer patients

The introducer technique is the optimal method for placing percutaneous endoscopic gastrostomy tubes in head and neck cancer patients

Systematic percutaneous fluoroscopic gastrostomy for concomitant radiochemotherapy of advanced head and neck cancer: optimization of therapy

Contact Info

Product

Resources

About